Repatriation Medical Authority - Notice of Investigation – Psoriasis - focussed

Overview

The Veterans' Entitlements Act 1986 (VEA), enacted by the Parliament of Australia, was introduced to provide a comprehensive framework for the entitlements of veterans, including access to pensions and compensation. This legislation was established to address the need for a structured approach to recognise and compensate veterans for disabilities and injuries incurred during their service. The Repatriation Medical Authority (the Authority), as a statutory body established under the VEA, is tasked with overseeing the administration and implementation of the Act. In line with its policy objectives, the Authority aims to ensure that veterans and their families receive fair and timely recognition and support for conditions related to their service. In furtherance of these objectives, the Authority has announced an investigation into stressors as factors in psoriasis, as outlined in the Notice of Investigation published in Gazette C2019G00238. This investigation is being conducted in the context of Statements of Principles Instrument No. 32 of 2012 concerning psoriasis. The Authority is inviting written submissions from eligible claimants, organisations representing veterans and their dependants, the Repatriation Commission or the Military Rehabilitation and Compensation Commission, and experts in relevant fields, to be submitted by 17 May 2019. The Authority's first meeting for this investigation is scheduled for 5 June 2019.

Scope and Application

The Repatriation Medical Authority, under the authority granted by section 196G of the Veterans' Entitlements Act 1986, has issued a notice of its intention to conduct an investigation into the impact of stressors as factors in psoriasis, specifically in the context of Statements of Principles Instrument No. 32 of 2012. This investigation is open to written submissions from eligible claimants under the VEA, representatives of veterans and their dependants, the Repatriation Commission or the Military Rehabilitation and Compensation Commission, and experts with relevant field knowledge. The Authority invites submissions from these stakeholders to ensure a comprehensive evaluation of the issue. Submissions must be submitted by 17 May 2019, either electronically via the RMA website, by email, or by post, adhering to the RMA Submission Guidelines for format and content. The Authority's first meeting for this investigation is scheduled for 5 June 2019. This Act applies to a broad range of stakeholders, including individuals eligible to claim pensions or compensation under the VEA or the Military Rehabilitation and Compensation Act 2004, organisations representing veterans and related groups, and experts with relevant expertise. The geographic scope of the investigation is national, as it pertains to the application of federal legislation concerning veterans' entitlements. The Act does not explicitly mention any exclusions or exemptions, but the requirement for submissions to be relevant to the investigation suggests that extraneous information will not be considered. The scope of the Act may be further refined through subordinate instruments that could detail specific aspects of the investigation or the types of evidence to be considered.

Key Provisions

The Veterans' Entitlements Act 1986 (VEA) mandates the Repatriation Medical Authority (the Authority) to investigate stressors as factors in psoriasis, as outlined in section 196G (196B(7A)). This investigation is conducted in the context of Statements of Principles Instrument No. 32 of 2012 concerning psoriasis. The Authority invites written submissions from eligible claimants under Part II or Part IV of the VEA, individuals eligible for compensation under section 319 of the Military Rehabilitation and Compensation Act 2004 (MRCA), organisations representing veterans or their dependents, the Repatriation Commission or the Military Rehabilitation and Compensation Commission, and experts relevant to the investigation. Submissions can be lodged electronically via the RMA website, by email, or by post, and must be received by 17 May 2019. The VEA imposes specific obligations on those invited to contribute to the investigation. Claimants, compensation-eligible individuals, and relevant organisations must submit their written submissions by the stipulated deadline. The Authority also requires experts to provide relevant and substantiated opinions on the stressors impacting psoriasis in the context of the investigation. The Repatriation Commission and the Military Rehabilitation and Compensation Commission may be required to provide insights and data pertinent to the investigation, ensuring a comprehensive analysis of the issue. Failure to comply with the requirements of the VEA, including the submission deadline, may result in significant consequences. While specific penalties are not outlined in the Gazette, breaches of statutory obligations can lead to civil or administrative penalties under Australian law. Such penalties may include fines or other sanctions deemed appropriate by the relevant authorities. Additionally, non-compliance could impact the credibility and validity of the investigation, potentially affecting the outcomes and benefits for affected veterans and their dependants. The Authority's investigation aims to enhance the understanding of the relationship between stressors and psoriasis, which could lead to better support and entitlements for veterans. The contributions of all parties are crucial for the thorough examination of this issue, and adherence to the statutory obligations is essential for the success of the investigation. The Repatriation Medical Authority's role is to ensure that all relevant information is considered, thereby facilitating informed decision-making in the context of veterans' entitlements and compensation.